Halting ionic shuttle to disrupt the synthetic machinery-Structural and molecular insights into the inhibitory roles of Bedaquiline towards Mycobacterium tuberculosis ATP synthase in the treatment of tuberculosis
- PMID: 31125144
- DOI: 10.1002/jcb.28891
Halting ionic shuttle to disrupt the synthetic machinery-Structural and molecular insights into the inhibitory roles of Bedaquiline towards Mycobacterium tuberculosis ATP synthase in the treatment of tuberculosis
Abstract
Therapeutic targeting of the adenosine triphosphate (ATP) machinery of Mycobacterium tuberculosis (Mtb) has recently presented a potent and alternative measure to halt the pathogenesis of tuberculosis. This has been potentiated by the development of bedaquiline (BDQ), a novel small molecule inhibitor that selectively inhibits mycobacterial F1 Fo -ATP synthase by targeting its rotor c-ring, resulting in the disruption of ATP synthesis and consequential cell death. Although the structural resolution of the mycobacterial C9 ring in co`mplex with BDQ provided the first-hand detail of BDQ interaction at the c-ring region of the ATP synthase, there still remains a need to obtain essential and dynamic insights into the mechanistic activity of this drug molecule towards crucial survival machinery of Mtb. As such, for the first time, we report an atomistic model to describe the structural dynamics that explicate the experimentally reported antagonistic features of BDQ in halting ion shuttling by the mycobacterial c-ring, using molecular dynamics simulation and the Molecular Mechanics/Poisson-Boltzmann Surface Area methods. Results showed that BDQ exhibited a considerably high ΔG while it specifically maintained high-affinity interactions with Glu65B and Asp32B , blocking their crucial roles in proton binding and shuttling, which is required for ATP synthesis. Moreover, the bulky nature of BDQ induced a rigid and compact conformation of the rotor c-ring, which impedes the essential rotatory motion that drives ion exchange and shuttling. In addition, the binding affinity of a BDQ molecule was considerably increased by the complementary binding of another BDQ molecule, which indicates that an increase in BDQ molecule enhances inhibitory potency against Mtb ATP synthase. Taken together, findings provide atomistic perspectives into the inhibitory mechanisms of BDQ coupled with insights that could enhance the structure-based design of novel ATP synthase inhibitors towards the treatment of tuberculosis.
Keywords: Mycobacterium tuberculosis; bedaquiline; ionophores.; molecular dynamic simulation; tuberculosis.
© 2019 Wiley Periodicals, Inc.
Similar articles
-
Triple Mycobacterial ATP-synthase mutations impedes Bedaquiline binding: Atomistic and structural perspectives.Comput Biol Chem. 2020 Apr;85:107204. doi: 10.1016/j.compbiolchem.2020.107204. Epub 2020 Jan 13. Comput Biol Chem. 2020. PMID: 31981966
-
Inhibition of M. tuberculosis and human ATP synthase by BDQ and TBAJ-587.Nature. 2024 Jul;631(8020):409-414. doi: 10.1038/s41586-024-07605-8. Epub 2024 Jul 3. Nature. 2024. PMID: 38961288
-
TBAJ-876 Retains Bedaquiline's Activity against Subunits c and ε of Mycobacterium tuberculosis F-ATP Synthase.Antimicrob Agents Chemother. 2019 Sep 23;63(10):e01191-19. doi: 10.1128/AAC.01191-19. Print 2019 Oct. Antimicrob Agents Chemother. 2019. PMID: 31358589 Free PMC article.
-
Current Perspective of ATP Synthase Inhibitors in the Management of the Tuberculosis.Curr Top Med Chem. 2021;21(18):1623-1643. doi: 10.2174/1568026621666210913122346. Curr Top Med Chem. 2021. PMID: 34517802 Review.
-
Unique structural and mechanistic properties of mycobacterial F-ATP synthases: Implications for drug design.Prog Biophys Mol Biol. 2020 May;152:64-73. doi: 10.1016/j.pbiomolbio.2019.11.006. Epub 2019 Nov 16. Prog Biophys Mol Biol. 2020. PMID: 31743686 Review.
Cited by
-
Unravelling the Structural Mechanism of Action of 5-methyl-5-[4-(4-oxo-3H-quinazolin-2-yl)phenyl]imidazolidine-2,4-dione in Dual-Targeting Tankyrase 1 and 2: A Novel Avenue in Cancer Therapy.Cell Biochem Biophys. 2022 Sep;80(3):505-518. doi: 10.1007/s12013-022-01076-2. Epub 2022 May 30. Cell Biochem Biophys. 2022. PMID: 35637423
-
Re-Understanding the Mechanisms of Action of the Anti-Mycobacterial Drug Bedaquiline.Antibiotics (Basel). 2019 Dec 11;8(4):261. doi: 10.3390/antibiotics8040261. Antibiotics (Basel). 2019. PMID: 31835707 Free PMC article. Review.
-
Battling BTK mutants with noncovalent inhibitors that overcome Cys481 and Thr474 mutations in Waldenström macroglobulinemia therapy: structural mechanistic insights on the role of fenebrutinib.J Mol Model. 2022 Oct 12;28(11):355. doi: 10.1007/s00894-022-05345-y. J Mol Model. 2022. PMID: 36222928
-
Exploring the Effects of Chirality of 5-methyl-5-[4-(4-oxo-3H-quinazolin-2- yl)phenyl]imidazolidine-2,4-dione and its Derivatives on the Oncological Target Tankyrase 2. Atomistic Insights.Curr Pharm Biotechnol. 2025;26(2):222-234. doi: 10.2174/1389201024666230330084017. Curr Pharm Biotechnol. 2025. PMID: 37005548
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous